• 1
    Schreiber W. Infectio. Infectious diseases in the history of medicine. Basle: Roche, 1987.
  • 2
    Wright DJM, Boyce MD. Ich bin ein berliner. Clin Microbiol Infect 2011; 17: 484486.
  • 3
    Stanek G, Reiter M. The expanding Lyme Borrelia complex—clinical significance of newly recognised genomic species? Clin Microbiol Infect 2011; 17: 485491.
  • 4
    Stanek G, Fingerle V, Hunfeld KP et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17: 6979.
  • 5
    Bhide M, Escudero R, Camafeita E, Gil H, Jado I, Anda P. Complement factor H binding by different Lyme disease and relapsing fever Borrelia in animals and human. BMC Res Notes 2009; 2: 134.
  • 6
    Brissette CA, Haupt K, Barthel D et al. Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun 2009; 77: 300306.
  • 7
    Grosskinsky S, Schott M, Brenner C et al. Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS ONE 2009; 4: e4858.
  • 8
    Grosskinsky S, Schott M, Brenner C, Cutler SJ, Simon MM, Wallich R. Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl Trop Dis 2010; 4: e698.
  • 9
    Hovis KM, Freedman JC, Zhang H, Forbes JL, Marconi RT. Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host–pathogen interaction. Infect Immun 2008; 76: 21132122.
  • 10
    Bykowski T, Babb K, von Lackum K, Riley SP, Norris SJ, Stevenson B. Transcriptional regulation of the Borrelia burgdorferi antigenically variable vlse surface protein. J Bacteriol 2006; 188: 48794889.
  • 11
    Dai Q, Restrepo B, Porcella S, Raffel S, Schwan T, Barbour A. Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol 2006; 60: 13291343.
  • 12
    Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis—dynamics of infection in the changing world. Clin Microbiol Infect 2011; 17: 492499.
  • 13
    Johnston V, Stockley J, Dockrell D et al. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. J Infect 2009; 59: 118.
  • 14
    Cutler SJ, Fooks AR, Van Der Poel WHM. Public health threat of new, reemerging, and neglected zoonoses in the industrialized world. Emerg Infect Dis 2010; 16: 17.
  • 15
    Visser MB, Ellen RP. New insights into the emerging role of oral spirochaetes in periodontal disease. Clin Microbiol Infect 2011; 17: 500510.